<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Although curable, trichomoniasis and its treatment are often challenging because of the drug's side effects. Generally, adverse effects include nausea, vomiting, constipation, cramping, and metallic taste. Other adverse effects include peripheral neuropathy, seizures, fatigue, dizziness, headache, and leukopenia (
 <xref rid="bib92" ref-type="bibr">Wendel and Workowski, 2007</xref>). Additionally, trichomonas is increasingly associated with other health complications like pelvic inflammatory disease and cervical cancer. Preterm births, low birth weights, stillbirth, neonatal death, sexual transmission, and acquisition of HIV infection are strongly associated with trichomoniasis (
 <xref rid="bib37" ref-type="bibr">Hirt et al., 2011</xref>). HIV-positive women may require multiple doses of metronidazole because of changes in vaginal ecology, interference of impaired immunity with single-dose treatment, and interaction of antiretroviral drugs with metronidazole (
 <xref rid="bib45" ref-type="bibr">Kissinger and Adamski, 2013</xref>). In men's case, 
 <italic>T. vaginalis</italic> infections are also associated with chronic prostatitis leading to aggressive prostate cancers, as observed from increased Prostate-Specific Antigen levels (
 <xref rid="bib49" ref-type="bibr">Langston et al., 2019</xref>; 
 <xref rid="bib85" ref-type="bibr">Suitcliffe et al., 2006</xref>).
</p>
